3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma

Table 2 Outcomes of the combination therapy and transcatheter arterial chemoembolization alone groups

Ref.	Year	1-yr survival		2-yr survival		3-yr survival
		TACE + 3D-CRT	TACE alone	TACE + 3D-CRT	TACE alone	TACE + 3D-CRT	TACE alone
Chia-Hsien Cheng et al[25]	2001			58.0%	56.0%
Lan et al[24]	2005	57.1%	61.7%	40.5%	30.0%	26.2%	16.7%
Li et al[23]	2003	73.2%	54.8%	58.7%	27.3%	41.9%	12.8%
Liao et al[22]	2010	74.0%	50.0%			30.0%	14.0%
Liu et al[21]	2005	66.5%	53.9%	48.4%	37.2%	37.4%	17.8%
Shang et al[20]	2007	78.0%	50.0%	60.0%	32.0%	34.0%	18.0%
Shim et al[19]	2005			36.8%	14.3%
Wu et al[18]	2004	90.2%	89.7%	75.6%	58.7%	44.6%	24.0%
Zeng et al[17]	2004	71.5%	59.6%	42.3%	26.5%	24.0%	11.1%
Zhao et al[16]	2006	82.0%	55.0%	63.0%	28.0%	43.0%	15.0%

TACE: Transcatheter arterial chemoembolization; 3D-CRT: Three-dimensional conformal radiotherapy.